polyethylene glycol 3350 17000 MG Powder for Oral Solution [PureLax]
RxNorm concept 1010732, branded drug (sbd). Prescribable name: Purelax 17 GM Powder for Oral Solution.
- RxCUI
- 1010732
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1010732 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- polyethylene glycol 3350 17000 MG (SCDC, consists of)
- polyethylene glycol 3350 17000 MG [PureLax] (SBDC, consists of)
- Powder for Oral Solution (DF, has dose form)
- PureLax (BN, has ingredient)
- polyethylene glycol 3350 17000 MG Powder for Oral Solution (SCD, tradename of)
Linked data
NDCs
- 43386031212
- 43386031217
- 59779019107
- 59779019130
- 59779030600
- 59779030601
- 59779030602
- 59779030603
- 59779030604
- 59779030609
- 59779030617
- 59779030619
- 59779030652
- 59779030653
- 59779030660
- 69842045801
- 69842045802
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1010732 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1010732 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1010732. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.